Wholesale Trade · Fiscal year end Dec 31

COSMO BIO COMPANY, LIMITED

3386

コスモ・バイオ株式会社

FIGI BBG000BL9QJ33386.T3386 JPCorp. no. 6010601023038

Latest half-year results

First half · fiscal year to 2026-12 · filed 2026-08-07

For the first half of the fiscal year to 2026-12: Revenue ¥5.9 billion (+9.5% YoY), Ordinary income ¥0.3 billion (-0.9% YoY), Net income ¥0.3 billion (+10.8% YoY).

	This period	Year on year
Revenue	¥5.9bn	+9.5%
Ordinary profit	¥340m	-0.9%
Net profit to owners	¥277m	+10.8%

From the securities report on EDINET, which states no forecast. History via /v1/companies/3386/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2025-12-31

Revenue: ¥10.8bn
Net income: ¥337m
ROE: 3.6%
Equity ratio: 74.0%
Dividend / share: ¥50
Employees: 182

Revenue · ¥bn

Net income · ¥m

Fiscal year	Revenue	Net income	Total assets	Net assets	ROE	EPS	Operating CF
2025-12-31	¥10.8bn	¥0.3bn	¥12.7bn	¥10.0bn	3.6%	¥59.26	¥0.6bn
2024-12-31	¥10.0bn	¥0.3bn	¥11.7bn	¥9.6bn	3.0%	¥45.05	¥0.2bn
2023-12-31	¥9.3bn	¥0.4bn	¥10.9bn	¥9.0bn	5.4%	¥75.97	¥0.7bn
2022-12-31	¥9.6bn	¥0.5bn	¥10.3bn	¥8.6bn	6.5%	¥89.13	¥0.3bn
2021-12-31	¥9.2bn	¥0.7bn	¥10.1bn	¥8.3bn	9.7%	¥126.94	¥0.6bn

Indicators

Computed by us from filings · fiscal year to 2025-12-31

Metric	Value	Percentile among listed companies
ROE, %	3.6	17.3
Ordinary margin	0.0454	34.6
Equity ratio, %	74	81.1
Revenue growth	0.0726	60.2
Net income growth	0.2863	63.8
Operating cash flow / assets	0.047	38.5

Policy-uncertainty measure2.08 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.

Trade & tariffs 2 Politics & geopolitics 2

Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 1.5% held by other listed companies.

Results wording balance: 0.00. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥20m of reported debt repriced by 50 basis points, a year's interest would rise by ¥0m, 0.0% of operating cash flow. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/3386/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them

Internal control, 2026-03-18: see filing 上記の評価の結果、当事業年度末日時点において、当社グループの財務報告に係る内部統制は有効であると判断いたしました。 Filing

Segments, votes and tender offers

Stated in EDINET filings

Latest voting result: 2026-03-24 · 剰余金の処分の件 · passed. /v1/companies/3386/voting

Ownership changes

All companies →

2025-11-18

Increase+1.05pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 16.22% from 15.17%.

S100X2OHFiler profile Original filing (PDF, Japanese)
2025-09-26

Increase+0.85pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 15.17% from 14.32%.

S100WQFKFiler profile Original filing (PDF, Japanese)
2024-08-08

Increase+1.01pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 14.32% from 13.31%.

S100U5ETFiler profile Original filing (PDF, Japanese)
2024-06-14

Increase+1.19pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 13.31% from 12.12%.

S100TL6MFiler profile Original filing (PDF, Japanese)
2024-04-01

Increase+1.02pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 12.12% from 11.10%.

S100T6U4Filer profile Original filing (PDF, Japanese)
2024-02-15

Increase+1.01pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 11.10% from 10.09%.

S100STULFiler profile Original filing (PDF, Japanese)
2023-12-27

Increase+1.05pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 10.09% from 9.04%.

S100SIZ5Filer profile Original filing (PDF, Japanese)
2023-12-27

Threshold

Holdings of Hikari Tsushin K.K. in COSMO BIO COMPANY, LIMITED (3386) moved above 10% (9.04% -> 10.09%).

S100SIZ5Filer profile Original filing (PDF, Japanese)
2023-11-02

Increase+1.00pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 9.04% from 8.04%.

S100S3F6Filer profile Original filing (PDF, Japanese)
2023-07-14

Increase+1.00pt

Hikari Tsushin K.K. raised holdings in COSMO BIO COMPANY, LIMITED (3386) to 8.04% from 7.04%.

S100RD74Filer profile Original filing (PDF, Japanese)

Trades by 5% holders

From the 60-day trade tables in 5% reports

Bought SoldHover a dot for the trade

Holder	Period	Net shares	Net % of shares	Avg. filed price	Range
株式会社UH Partners 3	2025-08-21 – 2025-11-11	+73,700	+1.23pt	¥1,211	¥1,211–1,211
株式会社UH5	2025-09-16 – 2025-09-30	+4,100	+0.06pt	—	—
光通信株式会社	2022-02-15 – 2025-09-19	+113,400	+1.84pt	—	—
株式会社UH Partners 2	2023-06-12 – 2025-09-19	+370,200	+5.92pt	¥970.75	¥943–980

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/3386/trades.

5% filings

Large shareholding reports on 3386

Filed	Filer	Stake	Change	Stated purpose
2025-11-18	Hikari Tsushin K.K.	16.22%	+1.05pt	pure investment
2025-09-26	Hikari Tsushin K.K.	15.17%	+0.85pt	pure investment
2024-08-08	Hikari Tsushin K.K.	14.32%	+1.01pt	pure investment
2024-06-14	Hikari Tsushin K.K.	13.31%	+1.19pt	pure investment
2024-04-01	Hikari Tsushin K.K.	12.12%	+1.02pt	pure investment
2024-02-15	Hikari Tsushin K.K.	11.10%	+1.01pt	pure investment
2023-12-27	Hikari Tsushin K.K.	10.09%	+1.05pt	pure investment
2023-11-02	Hikari Tsushin K.K.	9.04%	+1.00pt	pure investment
2023-07-14	Hikari Tsushin K.K.	8.04%	+1.00pt	pure investment
2023-03-03	Hikari Tsushin K.K.	7.04%	+1.01pt	pure investment

Cross-shareholdings

From the annual report's status of shareholdings

Listed strategic holdings: 4 issues
Book value: ¥2.6bn
Sold in the year: — 1 issues
Bought in the year: ¥30m 1 issues
Mutual, both reports: 4
Held by listed cos.: 4

Holds	Book value	Shares vs. prior year	Mutual
Shin Nippon Air Technologies Co., Ltd. 1952	¥2,264m	+100.0%	both reports
Kohjin Bio Co., Ltd. 177A	¥148m	0.0%	both reports
NICHIMO CO.,LTD. 8091	¥145m	0.0%	both reports
(株)NPT	¥17m	—	no
CAC Holdings Corporation 4725	—	sold all	both reports

Held by: Shin Nippon Air Technologies Co., Ltd. 1952, NICHIMO CO.,LTD. 8091, Kohjin Bio Co., Ltd. 177A, CAC Holdings Corporation 4725

Purposes, all holdings and mutual flags via /v1/companies/3386/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2025-12-31

Shareholder	Shares	Ratio
東京中小企業投資育成株式会社	1,152,000	20.30%
みずほ信託銀行株式会社退職給付信託コスモ石油口再信託受託者株式会社日本カストディ銀行	576,000	10.15%
UH Partners 2 投資事業有限責任組合	438,300	7.72%
光通信KK投資事業有限責任組合	375,500	6.61%
UH Partners 3 投資事業有限責任組合	119,500	2.10%
individual holder	96,000	1.69%
individual holder	82,300	1.45%
コスモ・バイオ従業員持株会	78,500	1.38%
individual holder	75,700	1.33%
individual holder	75,400	1.32%

Get this as JSON

GET /v1/companies/3386
GET /v1/companies/3386/financials
GET /v1/companies/3386/details
GET /v1/companies/3386/segments
GET /v1/companies/3386/voting
GET /v1/companies/3386/tender-offers
GET /v1/companies/3386/indicators
GET /v1/companies/3386/earnings-releases
GET /v1/events?ticker=3386
GET /v1/companies/3386/trades         
GET /v1/companies/3386/cross-holdings 
GET /v1/companies/3386/brief

Plans from $9 a month · Documentation